Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2007
10/10/2007EP1503746B1 Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
10/10/2007EP1487829B1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
10/10/2007EP1485090B1 Combinations comprising an epothilone derivative and an imidazotetrazinone
10/10/2007EP1454897B1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1404295B1 Sustained release drug delivery devices with coated drug cores
10/10/2007EP1399153B1 Pharmaceutical composition comprising orlistat and a fatty acid or salt thereof
10/10/2007EP1372608B1 Medical aerosol formulations
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1249450B1 Benzimidazole derivatives as human chymase inhibitors
10/10/2007EP1181304B1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/10/2007EP1154764B1 Use of epoxide hydrolase complexes for treating hypertension
10/10/2007EP1142879B1 Imidazole compounds and medicinal use thereof
10/10/2007CN101052718A Mutated amyloid protein
10/10/2007CN101052394A Treatment of acute myeloid leukemia with indolinone compounds
10/10/2007CN101052391A Peroxisome proliferator-activated receptor (PPAR) activator, and drugs, supplements, functional foods and food additives using the same
10/10/2007CN101052390A Medicine and food for preventing / improving functional digestive disorder
10/10/2007CN101052389A Agent for recovery from cerebral fatigue
10/10/2007CN101050215A Spiroazacyclic compounds as monoamine receptor modulators
10/10/2007CN101050199A (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
10/10/2007CN101050194A Derivative of bicyclo-octanes class, preparation method, and application of medicine
10/10/2007CN101049501A Composition of medicine for improving goodly hair quality of pet in mammalia, and method
10/10/2007CN101049469A Preparation of Chinese traditional medicine for treating keratosis palmaris et plantaris
10/10/2007CN101049454A Preparation of Chinese traditional medicine for treating keratosis of palm toe
10/10/2007CN101049425A Precious medicines of dispersing accumulation of pathogen for treating breast-dripping wet
10/10/2007CN101049131A Multifunctional core feedstuff for livestock and poultry, preparation method
10/10/2007CN100341885C Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
10/10/2007CN100341870C Glycosidase inhibitors and preparation thereof
10/10/2007CN100341862C Thiazolidine derivative and medicinal use thereof
10/10/2007CN100341579C Method for preparing gene therapeutic tissue engineering stent
10/10/2007CN100341555C Chinese traditional medicine in use for nursing body and regulating feeling and oneself
10/10/2007CN100341544C Health care product having immune regulating and antimutation action
10/10/2007CN100341539C Phellodendron bark disperse tablet and its preparation method
10/10/2007CN100341529C Combination of Tibet medicine of containing salt and possessing medicinal effect health care, and preparation metohd
10/10/2007CN100341520C aqualene composition with anti-fatigue and delaying ageing function
10/10/2007CN100341509C Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/10/2007CN100341496C Preventive or therapeutic agent for kidney disease
10/09/2007US7279595 Process for the preparation of high purity perindopril
10/09/2007US7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane
10/09/2007US7279496 suitable for the prophylaxis or treatment of psychoses, schizophrenia, depression, anxiety states, dementia, in particular Alzheimer's disease and Lewy bodies dementia, neurodegenerative disorders, etc.
10/09/2007US7279495 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279487 Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279484 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/09/2007US7279479 Method for the treatment of heart failure
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279473 Administered singly or in combination with a second antineoplastic agent; cyclin-dependent kinase inhibitors, antiproliferative agents; coupling and cyclization of a 1-aminopyridazinium salt with a 2-alkylthio-4-alkynyl pyrimidine compound
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279466 Anticarcinogenic agents
10/09/2007US7279330 Method for identifying modulating compounds of neurotransmitters
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide
10/09/2007US7279293 Constitutively active histamine H3 receptor mutants and uses thereof
10/09/2007US7279183 Particularly magnesium sulfate, magnesium oxide, magnesium phosphate, or magnesium chloride
10/09/2007US7279179 Liposome-entrapped topoisomerase inhibitors
10/09/2007US7279175 Reduce restenosis coating on medical device
10/09/2007US7279166 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
10/09/2007US7279157 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
10/09/2007US7279156 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells.
10/09/2007CA2252084C Cytoprotective compounds
10/09/2007CA2161857C Oxazolidinone derivatives as adhesion receptor antagonists
10/09/2007CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use
10/09/2007CA2099503C Synthetic alpha-l-iduronidase and genetic sequences encoding same
10/04/2007WO2007112138A2 Method of using guava extract and composition including guava extract
10/04/2007WO2007111514A1 Contrast agents for magnetic resonance imaging and spectroscopy consisting of a cyclic oligoamid core of 3 to 4 identical monomer units with 3 to 4 paramagnetic chelate side chains
10/04/2007WO2007111350A1 Agent for inhibition of angiogenesis or mesenchymal-type or amoeboid-type invasion of cancer cell
10/04/2007WO2007111321A1 Method of analyzing sulfated polysaccharide or sulfated oligosaccharide, pharmaceutical composition and drug containing sulfated polysaccharide or sulfated oligosaccharide, method of producing the pharmaceutical composition and the drug and method of treating, diagnosing, symptom-relieving and preventing disease
10/04/2007WO2007111294A1 Histamine release inhibitor
10/04/2007WO2007111242A1 Ameliorating agent for metabolic syndrome
10/04/2007WO2007111238A1 Oral agent for promoting synthesis of tissue collagen
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007111214A1 Trehalose compound and pharmaceutical comprising the compound
10/04/2007WO2007111038A1 Aggrecanase production inhibitor
10/04/2007WO2007111027A1 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
10/04/2007WO2007110243A1 Medicament, cosmetic or food product comprising an indol compound, the use thereof and the method of isolation thereof from sauerkraut
10/04/2007WO2007110241A1 Plant extracts, plant components and the uses thereof
10/04/2007WO2007110171A1 Substituted n-benzyl-n-phenylbenzenesulphonamides for treating viral infections
10/04/2007WO2007082309A3 Adenosine monophosphate for inducing torpor in a subject
10/04/2007WO2006030306A8 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
10/04/2007WO2005039546A3 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
10/04/2007US20070232696 Valproic acid and derivatives thereof as histone deacetylase inhibitors
10/04/2007US20070232692 Method of Treating Cancer Using Dithiocarbamate Derivatives
10/04/2007US20070232637 Combinations Comprising Antimuscarinic Agents and Pde4 Inhibitors
10/04/2007US20070232629 Adhesive Patch
10/04/2007US20070232628 Calcium receptor antagonists; 2-(2-hydroxy-phenyl)-3-(4-isopropyl-phenyl)-5,6,7,8-tetrahydro-3H-quinazolin-4-one; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral hypercalcemia, osteoporosis
1 ... 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 ... 1564